Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2B subunit beta (EIF2B2) is a regulatory component of the eIF2B complex, a guanine nucleotide exchange factor (GEF) essential for protein synthesis initiation. EIF2B2 plays a crucial role in regulating the GEF activity of the eIF2B complex, particularly in response to cellular stress and phosphorylation events. Mutations in EIF2B2 are associated with leukoencephalopathy with vanishing white matter (VWM), highlighting its importance for normal brain function.
Modulation of eIF2B complex activity, impacting global protein synthesis rates. Inhibition via phosphorylation-induced conformational changes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit beta (EIF2B2).